Organic & Biomolecular Chemistry
Paper
Methyl (E)-5-(4-methoxyphenyl)-5-(4,4,5,5-tetramethyl-1,3,2- 5.84–5.79 (dt, J 16, 1H), 3.71 (s, 3H), 2.79–2.68 (m, 1H),
dioxaborolan-2-yl)pent-2-enoate 3bii. Compound 3bii was 2.59–2.49 (m, 1H), 2.48–2.44 (m, 1H), 1.22 (s, 6H), 1.20 (s, 6H);
obtained as a yellow oil (367 mg, 53%): IR (neat) νmax 2984 (m), 13C NMR (101 MHz, CDCl3) δ 166.8, 148.1, 147.7, 140.1, 131.1,
2886 (s), 1722 (l), 1658 (m), 1650 (m), 1630 (s), 1510 (l), 1442 129.5, 128.4, 127.5, 121.7, 83.7, 51.1, 34.8, 33.6, 33.3, 30.2,
(m), 1368 (m), 1328 (m), 1248 (l), 1180 (m), 1140 (l), 1124 (s), 24.5; 11B NMR (128 MHz, CDCl3) δ 32.7; LRMS (ESI+) m/z
1042 (m), 1016 (s), 970 (m), 852 (m), 850 (m), 760 (m), 744 (m), [M + H] 373.5 (100%), 351.1 (91%), 372.6 (80%), 375.1 (75%);
710 (m); 1H NMR (400 MHz, CDCl3) δ 7.18–6.89 (m, 4H), HRMS (ESI+) m/z calculated C18H25BO4Cl [M] 350.1571 found
6.85–6.81 (dt, J 8, 1H), 5.82 (d, J 15, 1H), 3.80 (s, 3H), 3.71 350.1573; Chiral HPLC conditions OD-CHIRALCEL column
(s, 3H), 2.69 (m, 1H), 2.54 (m, 1H), 2.43 (m, 1H), 1.22 (s, 6H), (250 × 4.60 mm) fitted with guard cartridge (50 × 4.6 mm),
1.20 (s, 6H); 13C NMR (101 MHz, CDCl3): δ 167.0 (COOR), 25 °C, 0.8 mL min−1, 210 nm, hexane–iPrOH (99 : 1), tR
157.6, 148.9 (CHvCH–COOR), 133.5, 129.1, 121.4 (CHvCH– 10.7 min (S), tR = 13.0 min (R).
=
COOR), 113.9, 83.5, 55.1, 51.3, 35.3, 24.6, 24.5; 11B (128 MHz,
(E)-Methyl
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CDCl3) δ 32.6; LRMS (ESI+) m/z [M + H] 368.9 (100%), 364.0 hept-2-enoate 3fii. Compound 3fii was obtained as a yellow oil
(37%), 347.1 (35.5%), 363.5 (12%); HRMS (ESI+) m/z calculated (746 mg, 70%) with a Rf = 0.1: IR (neat) νmax 2980 (l), 2982 (l),
C19H27BO5 [M + H] 346.2066 found 346.2066; Chiral HPLC 2914 (m), 1726 (l), 1656 (m), 1440 (m), 1388 (l), 1322 (l), 1266 (l),
conditions OJ-H-CHIRALCEL column (250 × 4.60 mm) fitted 1200 (s), 1138 (l), 1048 (s), 974 (m), 846 (m), 760 (m), 744 (s);
with guard cartridge (50 × 4.6 mm), 25 °C, 0.8 mL min−1
,
1H NMR (400 MHz, CDCl3) δ 7.00–6.91 (dt, J 15.6, 7.2 Hz, 1H),
210 nm, hexane–iPrOH (97 : 3), tR = 12.6 min (R), tR = 14.7 min (S). 5.84–5.88 (dt, J 15.6, 1.5 Hz, 1H), 3.70 (s, 3H), 2.36–2.18
Methyl (E)-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaboro- (m, 2H), 1.50–1.36 (m, 2H), 1.26–1.18 (s, 12H), 1.12 (m, 1H),
lan-2-yl)hex-2-enoate 3cii. Compound 3cii was obtained as a 0.93–0.86 (t, J 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 167.5
yellow oil (161 mg, 60%): IR (neat) νmax 2986 (m), 2904 (s), (COOR), 150.1, 121.5 (CHvCH–COOR), 83.5, 51.7, 33.8,
2336 (l), 2370 (l), 1726 (l), 1704 (m), 1466 (m), 1464 (m), 1382 25.1 (C–CHvC), 24.0, 13.7; 11B NMR (128 MHz, CDCl3)
(l), 1380 (l), 1320 (l), 1308 (m), 1240 (m), 1144 (l), 1032 (m),
δ 34.1; LRMS (ESI+) m/z [M + H] 269.2 (74%), 290.8
1
1030 (m), 954 (s), 848 (m), 750 (s), 704 (m), 670 (m); H NMR (60%), 237.1 (54%); HRMS (ESI+) m/z calculated C14H26BO4
(400 MHz, CDCl3) δ 6.89–6.83 (m, 1H), 5.80 (d, J 16, 1H), 3.74 [M + H] 269.1924 found 269.1933; Chiral HPLC conditions
(s, 3H), 1.58 (s, 1H), 1. 26 (s, 6H), 1.25 (s, 6H), 1.09 (dd, J 6.8, OD-CHIRALCEL column (250 × 4.60 mm) fitted with guard
2.6 Hz, 3H), 0.93 (d, J 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3): cartridge (50 × 4.6 mm), 25 °C, 0.40 mL min−1, 210 nm, hexane–
δ 167.2 (COOR), 154.9 (CHvCH–COOR), 128.3, 127.2, 119.7 iPrOH (98 : 2), tR = 12.8 min (S), tR = 14.9 min (R).
(CHvCH–COOR), 83.1, 51.2, 39.2, 24.8 (C–CHvC), 19.0, 13.6;
Methyl (E)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hex-
11B NMR (128 MHz, CDCl3) δ 33.8; LRMS (ESI+) m/z 269.2 2-enoate 3gii. Compound 3g was obtained as a yellow oil
(100%), 237.1 (95%), 291.2 (66%); [M + H] HRMS (ESI+) m/z (662 mg, 65%) with a Rf = 0.1: IR (neat) νmax 2976 (s), 1720 (l),
calculated C14H25BO4 [M + H] 268.1960 found 268.1982.
1654 (s), 1458 (s), 1436 (s), 1368 (m), 1316 (m), 1266 (m), 1158
Methyl (E)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)oct- (s), 1142 (l), 1038 (s), 966 (m), 850 (m), 706 (m), 670 (m);
2-enoate 3dii. Compound 3dii was obtained as a yellow oil 1H NMR (400 MHz, CDCl3) δ 7.01–6.93 (dt, J 15.6, 7.2 Hz, 1H),
(832 mg, 74%) with a Rf = 0.33: IR (neat) νmax 2934 (m), 1722 5.85–5.79 (dt, J 15.6, 1.5 Hz, 1H), 3.72 (s, 3H), 2.40–2.31
(l), 1656 (s), 1434 (s), 1386 (m), 1316 (l), 1262 (m), 1140 (l), (m, 1H), 2.22–2.13 (m, 1H), 1.23 (s, 12H,), 1.01–0.95 (d, J 7.4,
1046 (s), 982 (m), 860 (m), 752 (l), 696 (m); 1H NMR (400 MHz, 3H); 13C NMR (101 MHz, CDCl3) δ 167.5(COOR), 150.0, 121.7
CDCl3) δ 7.03–6.95 (m, 1H), 5.86–5.82 (d, J 16 Hz, 1H), 3.73 (CHvCH–COOR), 83.6, 51.7, 35.9, 25.1 (C–CHvC), 15.5;
(s, 3H), 2.83–2.66 (m, 1H), 2.38–2.21 (m, 1H), 2.38–2.21 11B NMR (128 MHz, CDCl3) δ 33.9; LRMS (ESI+) m/z [M+] 236.2
(m, 1H), 1.61 (s, 6H), 1.35 (s, 6H), 0.92–0.89 (t, J 7.2, 3H); (58%), 235.6 (40%), 254.2 (25%); HRMS (ESI+) m/z calculated
13C NMR (101 MHz, CDCl3) δ 167.1 (COOR), 149.8, 121.2 C13H24BO4 [M
+ H] 254.1804 found 254.1817; Chiral
(CHvCH–COOR), 83.2, 51.3, 33.7, 33.0, 24.8 (C–CHvC), 22.0, HPLC conditions OD-CHIRALCEL column (250 × 4.60 mm)
14.30; 11B NMR (128 MHz, CDCl3) δ 33.9; LRMS (ESI+) m/z fitted with guard cartridge (50 × 4.6 mm), 25 °C, 1.0 mL
[M + H] 283.2 (100%), 282.1 (12%), 284.5 (10%); HRMS (ESI+) min−1, 210 nm, hexane–iPrOH (98 : 2), tR = 5.3 min (S), tR
m/z calculated C15H28BO4 [M + H] 282.2117, found 282.2130; 5.9 min (R).
=
Chiral HPLC conditions OD-CHIRALCEL column (250
×
Methyl
(E)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
4.60 mm) fitted with guard cartridge (50 × 4.6 mm), 25 °C, pent-2-enoate 3iii. Compound 3i was obtained as a yellow oil
0.7 mL min−1, 210 nm, hexane–iPrOH (99.5 : 0.5), tR = 8.7 min (S), (181 mg, 36%): IR (neat) νmax 2980 (m), 2944 (s), 2910 (s), 1724
tR = 11.1 min (R).
(l), 1658 (m), 1440 (m), 1368 (l), 1324 (l), 1274 (l), 1202 (m),
Methyl (E)-5-(4-chlorophenyl)-5-(4,4,5,5-tetramethyl-1,3,2- 1200 (s), 1140 (l), 1014 (s), 986 (s), 970 (m), 940 (s), 888 (s),
dioxaborolan-2-yl)pent-2-enoate 3eii. Compound 3eii was 848 (l), 834 (s), 762 (s), 716 (s), 706 (s); 1H NMR (400 MHz,
obtained as a yellow oil (377 mg, 54%): IR (neat) νmax 2982 (m), CDCl3) δ 7.03–6.93 (m, 1H), 5.80 (m, 1H), 3.74 (s, 3H),
2970 (s), 1722 (l), 1658 (m), 1492 (l), 1438 (m), 1372 (m), 2.65–2.57 (m, 1H), 1.26 (s, 6H), 1.24 (s, 6H), 1.11–1.10 (m, 3H),
1332 (m), 1274 (m), 1202 (m), 1200 (m), 1142 (l), 1092 (m), 0.95 (d, J 6.7, 1H), 0.89 (m, 1H); 13C NMR (101 MHz, CDCl3)
1
1012 (m), 970 (m), 844 (m), 842 (m), 796 (s), 702 (m); H NMR δ 167.2 (COOR), 157.5, 156.1, 118.0 (CHvCH–COOR), 116.5,
(400 MHz, CDCl3) δ 7.27–7.11 (m, 4H), 7.03–6.89 (m, 1H), 83.2, 83.0, 51.3, 32.5, 29.0, 24.8 (C–CHvC), 22.3, 21.4;
This journal is © The Royal Society of Chemistry 2015
Org. Biomol. Chem., 2015, 13, 5122–5130 | 5129